312
Participants
Start Date
February 20, 2024
Primary Completion Date
September 16, 2025
Study Completion Date
February 2, 2026
Itepekimab (SAR440340)
Pharmaceutical form: solution for injection in pre-filled syringe. Route of administration: subcutaneous
Placebo
Pharmaceutical form: solution for injection in pre-filled syringe. Route of administration: subcutaneous
Investigational Site Number : 1580004, Taipei
Investigational Site Number : 1580003, Taipei
Investigational Site Number : 1580002, New Taipei City
Investigational Site Number : 1580006, Taichung
Investigational Site Number : 1580005, Kaohsiung City
Investigational Site Number : 0320003, Buenos Aires
Investigational Site Number : 0320008, Buenos Aires
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number : 0320004, Buenos Aires
Investigational Site Number : 0320002, La Plata
Investigational Site Number : 0320005, San Miguel de Tucumán
Investigational Site Number : 2080004, Odense
Investigational Site Number : 0320007, Córdoba
Investigational Site Number : 0320006, Mendoza
Investigational Site Number : 2080001, Vejle
Investigational Site Number : 2080005, Aarhus
Investigational Site Number : 2080002, Aalborg
NYU Langone Medical Center- Site Number : 8400032, New York
Investigational Site Number : 2760010, Berlin
Clinical Research Associates of Central PA - Dubois- Site Number : 8400005, DuBois
Investigational Site Number : 7240012, Girona
Penn Medicine: University of Pennsylvania Health System- Site Number : 8400039, Philadelphia
Temple University Hospital- Site Number : 8400015, Philadelphia
Investigational Site Number : 3800002, Rozzano
Investigational Site Number : 3800001, Milan
Investigational Site Number : 2760001, Ahrensburg
Investigational Site Number : 2760004, Lübeck
Investigational Site Number : 3800003, Pavia
Southeastern Research Center- Site Number : 8400008, Winston-Salem
Investigational Site Number : 7240002, Madrid
Advanced Respiratory and Sleep Medicine - Huntersville- Site Number : 8400009, Huntersville
American Health Research - Charlotte- Site Number : 8400017, Charlotte
Investigational Site Number : 2500005, Brest
Medical University of South Carolina - Charleston - Jonathan Lucas Street- Site Number : 8400027, Charleston
Avanza Medical Research Center- Site Number : 8400018, Pensacola
Investigational Site Number : 7920002, Akdeniz
Clever Medical Research- Site Number : 8400001, Miami
My Community Research Center- Site Number : 8400023, Miami
Destiny Research Center- Site Number : 8400049, Palmetto Bay
High Quality Research- Site Number : 8400047, Miami
Private Practice - Dr. Frank Hull - Plantation- Site Number : 8400010, Plantation
Advanced Pulmonary Research Institute- Site Number : 8400007, Loxahatchee Groves
Investigational Site Number : 2500002, Montpellier
Investigational Site Number : 7920001, Istanbul
University of Alabama at Birmingham- Site Number : 8400040, Birmingham
Investigational Site Number : 7920004, İzmit
Investigational Site Number : 3800006, Reggio Emilia
Investigational Site Number : 2500006, Saint-Herblain
Investigational Site Number : 2760007, Essen
Pulmonary and Medicine Associates- Site Number : 8400057, Warren
University of Michigan Health System - Ann Arbor- Site Number : 8400055, Ann Arbor
Investigational Site Number : 2760002, Mainz
Investigational Site Number : 7920006, Samsun
Investigational Site Number : 2760005, Bendorf
Investigational Site Number : 2760003, Frankfurt
Northwestern Memorial Hospital- Site Number : 8400043, Chicago
Washington University- Site Number : 8400046, St Louis
University of Kansas Medical Center- Site Number : 8400045, Kansas City
Investigational Site Number : 2500001, Lyon
Plano Primary Care Clinic- Site Number : 8400019, Plano
Metroplex Pulmonary and Sleep Center- Site Number : 8400014, McKinney
Investigational Site Number : 2500003, Paris
The University of Texas Health Center at Tyler- Site Number : 8400053, Tyler
Pioneer Research Solutions, Inc.- Site Number : 8400048, Sugar Land
Allianz Research Institute CO- Site Number : 8400038, Aurora
Investigational Site Number : 2760011, Munich
Pulmonary Associates - Phoenix - East McDowell Road- Site Number : 8400012, Phoenix
Southern California Institute for Respiratory Diseases- Site Number : 8400002, Los Angeles
Investigational Site Number : 3800004, Palermo
Institute Healthcare Assessment- Site Number : 8400037, San Diego
Allianz Research Institute- Site Number : 8400013, Westminster
Investigational Site Number : 1560005, Beijing
Investigational Site Number : 1560007, Shenyang
Investigational Site Number : 1560008, Changchun
Investigational Site Number : 1560006, Shanghai
Investigational Site Number : 1560002, Shanghai
Investigational Site Number : 1560003, Xuzhou
Investigational Site Number : 1560001, Guangzhou
Investigational Site Number : 1560004, Chengdu
Investigational Site Number : 1520004, Quillota
Investigational Site Number : 3760006, Haifa
Investigational Site Number : 1520001, Talca
Investigational Site Number : 3760002, Petah Tikva
Investigational Site Number : 3760009, Ramat Gan
Investigational Site Number : 3760007, Tel Aviv
Investigational Site Number : 3760010, Tel Aviv
Investigational Site Number : 1520003, Santiago
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 3760004, Rehovot
Investigational Site Number : 3760008, Ashkelon
Investigational Site Number : 3760003, Jerusalem
Investigational Site Number : 3760001, Jerusalem
University of Connecticut Health Center- Site Number : 8400020, Farmington
Yale New Haven Hospital- Site Number : 8400065, New Haven
Oncoclínicas UMC- Site Number : 0760007, Uberlândia
Irmandade da Santa Casa de Misericórdia de Porto Alegre- Site Number : 0760005, Porto Alegre
Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760001, Porto Alegre
WM Pesquisas Clínicas em Doenças Respiratórias- Site Number : 0760004, Porto Alegre
Incor - Instituto do Coracao- Site Number : 0760002, São Paulo
Investigational Site Number : 1240003, Guelph
Investigational Site Number : 1240005, Sherbrooke
Investigational Site Number : 1240001, Trois-Rivières
Investigational Site Number : 2030006, Český Krumlov
Investigational Site Number : 2030002, Jindřichův Hradec
Investigational Site Number : 2030004, Kralupy nad Vltavou
Investigational Site Number : 2030003, Pilsen
Investigational Site Number : 2030005, Prague
Investigational Site Number : 2500004, Nice
Investigational Site Number : 2760009, Cottbus
Investigational Site Number : 3000001, Ioannina
Investigational Site Number : 3000003, Thessaloniki
Investigational Site Number : 3920002, Kamogawa
Investigational Site Number : 3920004, Himeji
Investigational Site Number : 3920005, Kiyose
Investigational Site Number : 3920001, Tokyo
Investigational Site Number : 3920003, Tokyo
Investigational Site Number : 5280002, Alkmaar
Investigational Site Number : 5280005, Amsterdam
Investigational Site Number : 5280004, Breda
Investigational Site Number : 5280001, Rotterdam
Investigational Site Number : 5280003, The Hague
Investigational Site Number : 6160005, Lodz
Investigational Site Number : 6160001, Bialystok
Investigational Site Number : 6160003, Lodz
Investigational Site Number : 6160006, Wejherowo
Investigational Site Number : 6160002, Ostrowiec Świętokrzyski
Investigational Site Number : 7240007, Barcelona
Investigational Site Number : 7240003, Barcelona
Investigational Site Number : 7240006, Barcelona
Investigational Site Number : 7240001, L'Hospitalet de Llobregat
Investigational Site Number : 7920003, Adana
Investigational Site Number : 7920005, Ankara
Investigational Site Number : 8260009, Cambridge
Investigational Site Number : 8260008, Norwich
Investigational Site Number : 8260003, North Shields
Investigational Site Number : 8260004, Lancaster
Investigational Site Number : 8260001, Newcastle upon Tyne
Investigational Site Number : 8260005, Reading
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY